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Abstract
Introduction: The Department of Health and Human Services’ 2010 Strategic Framework on Multiple Chronic 
Conditions called for the identification of common constellations of conditions in older adults. Objectives: To 
analyze patterns of conditions constituting multimorbidity (CCMM) and expenditures in a US representative 
sample of midlife and older adults (50–64 and ≥65 years of age, respectively). Design: A cross-sectional study 
of the 2010 Health and Retirement Study (HRS; n=17,912). The following measures were used: (1) count and 
combinations of CCMM, including (i) chronic conditions (hypertension, arthritis, heart disease, lung disease, 
stroke, diabetes, cancer, and psychiatric conditions), (ii) functional limitations (upper body limitations, lower 
body limitations, strength limitations, limitations in activities of daily living, and limitations in instrumental 
activities of daily living), and (iii) geriatric syndromes (cognitive impairment, depressive symptoms, inconti-
nence, visual impairment, hearing impairment, severe pain, and dizziness); and (2) annualized 2011 Medicare 
expenditures for HRS participants who were Medicare fee-for-service beneficiaries (n=5,677). Medicaid ben-
eficiaries were also identified based on their self-reported insurance status. Results: No large representations of 
participants within specific CCMM categories were observed; however, functional limitations and geriatric syn-
dromes were prominently present with higher CCMM counts. Among fee-for-service Medicare beneficiaries 
aged 50–64 years, 26.7% of the participants presented with ≥10 CCMM, but incurred 48% of the expenditure. 
In those aged ≥65 years, these percentages were 16.9% and 34.4%, respectively. Conclusion: Functional limita-
tions and geriatric syndromes considerably add to the MM burden in midlife and older adults. This burden is 
much higher than previously reported.
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Introduction
In 2011, nearly two thirds of Medicare fee-for-service 
(FFS) beneficiaries had two or more chronic condi-
tions, and 15% presented with six or more chronic 
conditions [1]. In addition, the average annual Medi-
care expenditures for beneficiaries with six or more 
chronic conditions was approximately threefold that of 
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beneficiaries with four or five conditions (USD 31,543 
vs. USD 11,628) [1]. 
The co-occurrence of multiple chronic conditions 
with functional limitations [2–10] and geriatric syn-
dromes [11–14] has been well documented. In parallel, 
the shared risk factors between geriatric syndromes and 
functional dependence have also been described. In a 
1995 study, Tinetti et al. [15] showed that decreased 
upper extremity impairment, decreased lower body 
impairment, sensory impairment, and affective impair-
ment were predisposing factors for incontinence, falls, 
and functional dependence. Moreover, cognitive 
impairment has been shown to be associated with dis-
ability [16,17] and limitations in instrumental activities 
of daily living [18]. Extending the intricate association 
between geriatric syndromes and functional depend-
ence to that of chronic conditions, Martinez et al. [19] 
demonstrated that both chronic obstructive pulmonary 
disease and mild cognitive impairment increased the risk 
of disability.
Building on the above line of inquiry, we have 
adopted a more encompassing definition of multimor-
bidity (MM) by accounting for functional limitations 
and geriatric syndromes, rather than chronic conditions 
alone, thus drawing a clear distinction between MM and 
multiple chronic conditions. We have also shown that 
the co-occurrence of functional limitations and ger-
iatric syndromes with chronic conditions is (i) highly 
prevalent in older adults, and (ii) has cumulative effects 
relative to health outcomes [20], thus reflecting greater 
disease burden. Such an encompassing approach is all 
the more relevant with the aging of the population, 
given that the findings will guide future developments 
in clinical care, research methodology, and healthcare 
policy. This is best reflected through the Department of 
Health and Human Services’ 2010 Strategic Framework 
on Multiple Chronic Conditions [21], which calls for 
studies to “understand the epidemiology of multiple chronic 
conditions” (Goal 4, Objective B), while highlighting the 
limited research about “the constellations of conditions that 
are most prevalent and most important in terms of disability 
among individuals with MCC.” This document further 
calls for additional research identifying the “most com-
mon patterns of MCC,” which can help in “targeting specific 
interventions for specific subgroups and monitoring the impact of 
those interventions.”
In the present study, we use rich survey data from the 
Health and Retirement Study (HRS) on a US represent-
ative sample of midlife and older adults to analyze the 
number of chronic conditions, functional limitations, 
and geriatric syndromes constituting MM across socio-
demographic strata. We build upon our previous work 
[20] in two key ways. First, we provide a more detailed 
characterization of the profile of MM in midlife and 
older adults. Rather than examining the co-occurrence 
of chronic conditions, functional limitations, and geri-
atric syndromes in broad terms, we report on the most 
frequently co-occurring specific conditions constituting 
MM (CCMM). Second, in a subset of the study popu-
lation receiving care through the Medicare FFS system, 
we analyze the number of CCMM in relation to Medi-
care expenditures. Given potential differences between 
younger (50–64 years of age) and older (≥65 years of 
age) Medicare beneficiaries in their MM patterns and 
expenditures, we conducted these analyses after stratify-
ing the data by age. 
The study hypotheses were: (i) older age is associated 
with a greater count of CCMM; (ii) a greater count of 
CCMM is associated with higher expenditures; (iii) a 
relatively smaller percentage of Medicare beneficiaries 
with a high count of CCMM incur a high percentage 
of Medicare expenditures; and (iv) rather than a large 
representation of HRS participants with specific com-
binations of CCMM, there are certain conditions, or 
combinations of conditions, that appear frequently with 
greater counts of CCMM.
Objectives
The objectives of this study were to analyze patterns of 
CCMM and expenditures in a US representative sample 
of midlife and older adults (50–64 and ≥65 years of age, 
respectively).
Methods
A cross-sectional study was performed using data from 
the 2010 HRS and linked Medicare data from 2010 
to 2011. The study was approved by the University of 
Michigan, which administers the HRS; the Centers for 
Medicare & Medicaid Services (CMS) privacy board; 
and the Institutional Review Board at Case Western 
Reserve University.
Data sources
The HRS
Launched in 1992, and supported by the National Insti-
tute on Aging, the HRS is a biennial survey of US 
representative sample of adults aged 50 years or older. 
To date, approximately 30,000 older adults have been 
surveyed by the HRS. In addition to sociodemographic 
variables, the HRS includes a broad range of variables on 
self-reported chronic conditions, functional status, cog-
nitive status, and depressive symptoms, among others.
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The Medicare beneficiary summary file (MBSF)
Individuals who agree to have their HRS survey data 
linked to their Medicare records can also be identified in 
Medicare administrative files. Thus, the MBSF was used 
to retrieve relevant data for HRS respondents who were 
Medicare beneficiaries, including those who enrolled in 
Medicare before age-qualifying for the program. The 
MBSF carries monthly variables indicating beneficia-
ries’ enrollment in Medicare managed care programs, 
making it possible to identify Medicare beneficiaries 
receiving care through the traditional system. The 
MBSF also includes the total Medicare expenditures 
incurred by FFS beneficiaries during a given calendar 
year. Thus, the MBSF was used to identify Medicare 
FFS beneficiaries and to analyze expenditures relative to 
the count of CCMM identified from the HRS.
The linked HRS–MBSF file
This cross-reference file, which is made available to 
researchers when accessing the restricted linked HRS–
MBSF files, enables portions of the records from each 
of the HRS and MBSF to be linked and to construct a 
unique record for each individual in the study population.
Study population
A total of 18,005 individuals were surveyed in 2010. 
This did not include proxy respondents or former HRS 
participants who died prior to the 2010 scheduled inter-
view. Records for individuals with missing data on study 
variables (n=93) were excluded, leaving a total of 17,912 
in the study population.
As noted above, Medicare data were obtained from 
the MBSF for 5,677 individuals (n=648 for 50–64-year 
olds and n=5,029 for ≥65-year olds) who were enrolled 
in Medicare, regardless of their age, and who had 
received their care services through the FFS program. 
Key variables of interest
Multimorbidity
Variables included in our definition of MM were not 
only self-reported chronic conditions but also functional 
limitations and geriatric syndromes. The following 
specific conditions were accounted for in each of the 
aforementioned broad rubrics:
 • Self-reported chronic conditions (possible total count 
of eight), indicating whether the individual was ever 
told by a physician that he or she had hypertension, 
arthritis, heart disease, lung disease, non-skin cancer, 
stroke, diabetes, and psychiatric conditions.
 • Functional limitations (possible count of five): upper 
body limitations (e.g. difficulty picking up a coin from 
the floor or reaching overhead); lower body limitations 
(e.g. difficulty climbing stairs or walking around the 
block); strength limitations (e.g. ability to lift 4.5 kg or 
difficulty in moving a large object); limitations in activ-
ities of daily living (ADL; e.g. crossing a room, dressing, 
bathing); and limitations in instrumental ADL (IADL; 
e.g. ability to prepare meals or manage money).
 • Geriatric syndromes (possible count of seven): poor 
cognitive functioning (lowest tertile of cognitive 
score obtained from the Telephone Interview Cogni-
tive Survey [TIC]); depressive symptoms (answered 
“yes” to at least four of the eight items of the Center 
for Epidemiological Studies-Depression [CES-D] 
scale); visual impairment; hearing impairment; often 
experience severe pain; incontinence; and dizziness.
Thus, the total count of conditions that an individual 
may potentially present with is 20.
Annualized median Medicare expenditures
The MBSF includes the total amount of Medicare expen-
diture incurred by a beneficiary in a given year. To account 
for partial-year enrollment caused by entering mid-year 
or exiting the program (mainly through death), we cal-
culated the per-person per month (PPPM) expenditures 
by aggregating the Medicare expenditures in 2010 and 
2011, and dividing the total amount by the total number 
of FFS months during the 2-year period. To obtain more 
robust estimates, we calculated the PPPM based on 2-year 
rather than 1-year data. To annualize, we then multiplied 
the PPPM expenditures by 12, and afterwards by 0.01 to 
account for inflation from 2010 to 2011. Data are presented 
as median to address the skewedness of expenditures.
Other variables of interest
Other data retrieved from the HRS included age (<64, 
65–74, 75–74, and ≥85 years); sex; race (Non-Hispanic 
White, Non-Hispanic Black, Hispanic, and other); mar-
ital status (married and non-married); years of education 
(<9, 9–11, 12, 13–15, 16, and ≥17); income (<100% of 
the federal poverty level, 100–199%, 200–299%, and 
≥300%); and self-reported Medicaid receipt (yes/no). 
Analysis 
Using survey weights to account for the complex sur-
vey design of the HRS, we conducted a descriptive 
analysis to identify patterns of CCMM count in the 
socio demographic strata of our study population and to 
report the median annualized expenditures for CCMM. 
To analyze the combinations of CCMM, we used two 
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Tables 2A (age 50–64 years) and 2B (age ≥65 years). The 
conditions are color-shaded to highlight the frequency 
with which certain conditions appear across the differ-
ent count categories. 
Among individuals aged 50–64 years, the most com-
mon condition was hypertension (50.0%), whether 
presenting with or without the co-occurrence of any 
other condition (Table 2A). The most common dyad 
was limitations in lower body functioning and strength 
limitations (37.2%). For triads, the most common con-
ditions were hypertension, limitations in lower body 
functioning, and strength limitations (24.0%). The most 
common quadriad consisted of hypertension, arthritis, 
limitations in lower body functioning, and strength lim-
itations (16.4%). The most common pentad included the 
aforementioned conditions, in addition to limitations in 
upper body functioning (11.0%) (Table 2A). 
Among individuals aged ≥65 years, the most frequent 
monads, dyads, triads, quadriads, and pentads were 
identical to those observed in the younger age group 
(50–64 years), but the percent of individuals present-
ing with these combinations of conditions differed 
markedly (Tables 2A and 2B). For example, 72.3% of 
adults aged ≥65 years had hypertension compared with 
50.0% of those in the younger age group, whether or 
not hypertension co-occurred with any other condition. 
Similarly, 25.3% of individuals aged ≥65 years presented 
with the pentad of hypertension, arthritis, limitations in 
upper body functioning, limitations in lower body func-
tioning, and strength limitations, compared with only 
11.0% of those in the younger age group. Interestingly, 
the most common monad, dyad, quadriad, and pentad 
appearing in combinations of conditions was identical 
across the two age groups.
The percent of individuals presenting with the top 
five most frequent combinations of CCMM is shown in 
Tables 3A (age 50–64 years) and 3B (age ≥65 years). As 
noted above, this analysis differs from the one presented 
in Tables 2A and 2B in that it accounts for the exact 
combinations of conditions with which individuals 
present, without the co-occurrence of other conditions. 
Again, for parsimony, only combinations up to a count 
of five are shown.
In both age groups of the population, our analysis did 
not show any large representations of HRS participants 
with specific CCMM (Tables 3A and 3B). Rather, we 
observed great heterogeneity in the grouping of indi-
viduals with specific combinations of CCMM. For 
example, for individuals aged 50–64 years, the most 
frequent CCMM for two conditions (hypertension 
and poor cognition) accounted for only 96 of the 1,422 
individuals (6.8%) presenting with two conditions 
(Table 3A). Similarly, for individuals aged ≥65 years, the 
most frequent CCMM for two conditions (hypertension 
different approaches. First, we used association rule 
mining (ARM) to identify the most common monads, 
dyads, triads, quadriads, and pentads, and to determine 
whether or not they co-occur with any other conditions. 
ARM was developed in the realm of marketing research 
to identify items that are commonly purchased together 
and is now applied in a variety of settings, including 
medicine and bioinformatics [22–24]. Second, we iden-
tified the five most frequently observed specific CCMM 
that were identified in each of the count categories. For 
parsimony, we limited our reporting of CCMM to the 
top five most-frequently observed combinations. We 
used R version 3.3.1 and “arules” package 1.4-1 for the 
ARM analysis, and SAS version 9.3 for all other analyses.
Results
Of the 17,912 HRS participants included in our study, 
about half (50.9%) were younger than 65 years of age, 
42.7% were men, 31.3% were non-Hispanic Black 
or Hispanic, 21% had less than 12 years of education, 
32.3% had an income of less than 200% of the federal 
poverty level, and 6.2% were on Medicaid or dually eli-
gible Medicare–Medicaid beneficiaries (Table 1).
Only 15.6% of study participants presented with no 
or only one condition, and 22.3% presented with two or 
three conditions. The remaining 62% of the population 
presented with at least four conditions, including 11.4% 
with 10 or more conditions.
A higher count of conditions was observed among 
older than younger individuals. For example, 7.4% of 
individuals aged 50–64 years presented with 10 or more 
conditions, compared with 31.8% of those aged ≥85 
years. Similarly, higher counts were observed among 
women than among men; among those with lower 
income and/or educational attainment than among 
those with higher income and/or educational attain-
ment; and among those on Medicaid or dually eligible 
Medicare–Medicaid beneficiaries (Table 1).
Our analysis of the combinations of conditions is 
described below, and is as follows: first, we show the most 
common combinations of conditions (monads, dyads, etc.) 
that appear regardless of whether or not they co-occur 
with other conditions (e.g. combination of hyperten-
sion and arthritis, with or without the co-occurrence 
of strength limitations or incontinence); next, we show 
the number of individuals with specific combinations of con-
ditions, without the co-occurrence of other conditions; 
and lastly, we present results showing the association 
between the number of conditions with which individ-
uals present and the Medicare expenditures.
The most common monads, dyads, triads, quadriads, and 
pentads of combinations within CCMMs are shown in 
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and arthritis) accounted for 80 of the 620 individuals 
(12.9%) presenting with this combination of conditions 
(Table 3B). Of note, the combination of hypertension 
and arthritis was also frequently observed in individuals 
of both age groups with CCMM counts greater than 
two. More over, we note the prominence of functional 
limitations in these combinations of conditions, espe-
cially lower body limitations and strength limitations. In 
particular, the combination of limitations in lower body 
functioning and strength limitations begins to emerge 
– and is consistently present – among individuals pre-
senting with a CCMM count of three or greater.
Figure 1 shows expenditure data related to counts 
of CCMM, stratified by age group. These analyses are 
limited to HRS participants who are also Medicare 
beneficiaries, and receive their care through the FFS 
program; hence, the distribution of individuals by the 
CCMM is different from that described above for all 
HRS participants. The median annualized expenditures 
increases considerably with the number of CCMM 
with which individuals present. However, rather than 
a straight line, the association is “J-shaped,” showing a 
sharp increase in the expenditures with greater CCMM 
counts.
The distribution of individuals and expenditures by 
CCMM, and stratified by age, is shown in Figures 2A 
and 2B. In individuals aged 50–64 years, 26.7% of the 
participants presented with 10 or more CCMM, but 
incurred almost half (48.2%) of the expenditures  (Figure 
2A). In those aged ≥65 years, 17.0% presented with 10 or 
more CCMM and incurred 34.4% of the expenditures 
(Figure 2B).
Discussion
Using a unique resource combining survey and adminis-
trative data for a representative sample of US midlife and 
Table 1 Distribution of the study population by sociodemographic characteristics and by number of conditions constituting multimorbidity.
 
 
Number of chronic conditions, functional limitations, and geriatric syndromes
N (% of total study 
population)
0 or 1
N (%)
 2 or 3
N (%)
 4 or 5
N (%)
 6 or 7
N (%)
 8 or 9
N (%)
 ≥10
N (%)
Total population  17,912 (100.0)  2,802 (15.6)  4,000 (22.3)  3,743 (20.9)  3,200 (17.9) 2,129 (11.9)  2,038 (11.4)
Age, years
 50–64  9,111 (50.9)  2,285 (25.1)  2,554 (28.0)  1,751 (19.2)  1,170 (12.8) 680 (7.5)  671 (7.4)
 65–74  4,254 (23.7)  391 (9.2)  929 (21.8)  1,086 (25.5)  938 (22.0)  499 (11.7)  411 (9.7)
 75–84  3,246 (18.1)  112 (3.5)  443 (13.6)  734 (22.6)  808 (24.9)  607 (18.7)  542 (16.7)
 ≥85  1,301 (7.3)  14 (1.1)  74 (5.7)  172 (13.2)  284 (21.8)  343 (26.4)  414 (31.8)
Sex
 Male  7,640 (42.7)  1,439 (18.8)  1,897 (24.8)  1,610 (21.1)  1,262 (16.5) 765 (10.0)  667 (8.7)
 Female  10,272 (57.3)  1,363 (13.3)  2,103 (20.5)  2,133 (20.8)  1,938 (18.9) 1,364 (13.3)  1,371 (13.3)
Race/ethnicity
  White Non-
Hispanic
 11,770 (65.7)  1,881 (16.0)  2,621 (22.3)  2,544 (21.6)  2,138 (18.2) 1,388 (11.8)  1,198 (10.2)
  Black Non-
Hispanic
 3,346 (18.7)  439 (13.1)  706 (21.1)  683 (20.4)  601 (18.0)  413 (12.3)  504 (15.1)
 Hispanic  2,264 (12.6)  356 (15.7)  524 (23.1)  434 (19.2)  379 (16.7)  280 (12.4)  291 (12.9)
 Other  532 (3.0)  126 (23.7)  149 (28.0)  82 (15.4)  82 (15.4)  48 (9.0)  45 (8.5)
Marital status
 Married  7,250 (40.5)  822 (11.3)  1,339 (18.5)  1,382 (19.1)  1,377 (19.0) 1,090 (15.0)  1,240 (17.1)
 Not married  10,662 (59.5)  1,980 (18.6)  2,661 (25.0)  2,361 (22.1)  1,823 (17.1) 1,039 (9.7)  798 (7.5)
Education, years
 <9  1,696 (9.5)  98 (5.8)  249 (14.7)  296 (17.5)  339 (20.0)  306 (18.0)  408 (24.1)
 9–11  2,068 (11.5)  133 (6.4)  298 (14.4)  408 (19.7)  447 (21.6)  376 (18.2)  406 (19.6)
 12  5,638 (31.5)  700 (12.4)  1,178 (20.9)  1,224 (21.7)  1,172 (20.8) 717 (12.7)  647 (11.5)
 13–15  4,256 (23.8)  752 (17.7)  1,044 (24.5)  944 (22.2)  702 (16.5)  432 (10.2)  382 (9.0)
 16  2,210 (12.3)  579 (26.2)  642 (29.0)  438 (19.8)  278 (12.6)  167 (7.6)  106 (4.8)
 ≥17  2,044 (11.4)  540 (26.4)  589 (28.8)  433 (21.2)  262 (12.8)  131 (6.4)  89 (4.4)
Income as % of federal poverty level
 <100  2,315 (12.9)  183 (7.9)  355 (15.3)  447 (19.3)  416 (18.0)  376 (16.2)  538 (23.2)
 100–199  3,479 (19.4)  269 (7.7)  514 (14.8)  643 (18.5)  769 (22.1)  625 (18.0)  659 (18.9)
 200–299  2,954 (16.5)  333 (11.3)  590 (20.0)  638 (21.6)  617 (20.9)  427 (14.5)  349 (11.8)
 ≥300  9,164 (51.2)  2,017 (22.0)  2,541 (27.7)  2,015 (22.0)  1,398 (15.3) 701 (7.6)  492 (5.4)
Medicaid status
 No  16,796 (93.8)  2,784 (16.6)  3,935 (23.4)  3,598 (21.4) 2,995 (17.8) 1,872 (11.1)  1,612 (9.6)
 Yes  1,116 (6.2)  18 (1.6)  65 (5.8)  145 (13.0)  205 (18.4)  257 (23.0)  426 (38.2)
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Table 2A Five most frequently observed monads, dyads, triads, quadriads, and pentads appearing in combinations of conditions constituting multimor-
bidity among adults aged 50–64 years.
N (% of total n=9,111)
Hypertension 4,558 (50.0)
Limitations / Strength 4,263 (46.8)
Limitations / Lower body 4,250 (46.6)
Arthritis 3,643 (40.0)
Limitations / Upper body 2,444 (26.8)
Limitations / Lower body Limitations / Strength 3,389 (37.2)
Hypertension Limitations / Lower body 2,635 (28.9)
Hypertension Limitations / Strength 2,590 (28.4)
Arthritis Limitations / Strength 2,538 (27.9)
Arthritis Limitations / Lower body 2,509 (27.5)
Hypertension Limitations / Lower body Limitations / Strength 2,192 (24.0)
Arthritis Limitations / Lower body Limitations / Strength 2,187 (24.0)
Limitations / Upper body Limitations / Lower body Limitations / Strength 1,994 (21.9)
Hypertension Arthritis Limitations / Lower body 1,670 (18.3)
Hypertension Arthritis Limitations / Strength 1,669 (18.3)
Hypertension Arthritis Limitations / Strength Limitations / Lower body 1,496 (16.4)
Hypertension Limitations / Lower body Limitations / Strength Limitations / Upper body 1,386 (15.5)
Arthritis Limitations / Lower body Limitations / Strength Limitations / Upper body 1,386 (15.2)
Hypertension Arthritis Limitations / Strength Limitations / Upper body 1,043 (11.5)
Hypertension Limitations / Lower body Limitations / Upper body Diabetes 1,039 (11.4)
Hypertension Limitations / Lower body Limitations / Strength Limitations / Upper body Arthritis 1,006 (11.0)
Hypertension Limitations / Lower body Limitations / Strength Limitations / Upper body Impaired vision 649 (7.1)
Arthritis Limitations / Lower body Limitations / Strength Limitations / Upper body Limitations / IADL 630 (6.9)
Hypertension Limitations / Lower body Limitations / Strength Limitations / Upper body Limitations / IADL 629 (6.9)
Hypertension Limitations / Lower body Limitations / Strength Limitations / Upper body Depressive Symptoms 612 (6.7)
M
on
ad
s
D
ya
ds
Tr
ia
ds
Qu
a
dr
ia
ds
Pe
nt
ad
s
IADL, instrumental activities of daily living.
Table 2B Five most frequently observed monads, dyads, triads, quadriads, and pentads appearing in combinations of conditions constituting multimor-
bidity among adults aged ≥65 years. 
N (% of total n=8,801)
Hypertension 6,367 (72.3)
Limitations / Lower body 6,201 (70.5)
Arthritis 6,085 (69.1)
Limitations / Strength 5,844 (66.4)
Limitations / Upper body 3,807 (43.3)
Limitations / Lower body Limitations / Strength 5,058 (57.5)
Hypertension Limitations / Lower body 4,786 (54.4)
Arthritis Limitations / Lower body 4,784 (54.4)
Hypertension Arthritis 4,626 (52.6)
Arthritis Limitations / Strength 4,590 (52.2)
Arthritis Limitations / Lower body Limitations / Strength 4,074 (46.3)
Hypertension Limitations / Lower body Limitations / Strength 3,956 (45.0)
Hypertension Arthritis Limitations / Lower body 3,784 (43.0)
Hypertension Arthritis Limitations / Strength 3,626 (41.2)
Limitations / Lower body Limitations / Upper body Limitations / Strength 3,227 (36.7)
Hypertension Arthritis Limitations / Lower body Limitations / Strength 3,262 (37.1)
Arthritis Limitations / Upper body Limitations / Lower body Limitations / Strength 2,676 (30.4)
Hypertension Limitations / Upper body Limitations / Lower body Limitations / Strength 2,627 (29.8)
Hypertension Arthritis Limitations / Upper body Limitations / Lower body 2,372 (27.0)
Hypertension Arthritis Limitations / Upper body Limitations / Strength 2,328 (26.5)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Limitations / Upper body 2,228 (25.3)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Heart disease 1,604 (18.3)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Poor cognition 1,390 (15.8)
Hypertension Limitations / Upper body Limitations / Lower body Limitations / Strength Heart disease 1,384 (15.7)
Arthritis Limitations / Upper body Limitations / Lower body Limitations / Strength Heart disease 1,356 (15.4)
M
on
ad
s
D
ya
ds
Tr
ia
ds
Qu
ad
ria
ds
Pe
nt
ad
s
Multimorbidity constellations and costs 39
© 2017 The Authors
 Published by Swiss Medical Press GmbH | www.swissmedicalpress.com Journal of Comorbidity 2017;7(1):33–43
Table 3A Most frequent combinations of conditions constituting multimorbidity among adults aged 50–64 years, by number of conditions (top five only).
N (%) N (% of total n=9,111)
Hypertension 389 (27.8)
Poor cognition 173 (12.3)
Arthritis 162 (11.6)
Impaired vision 93 (6.6)
Incontinence 92 (6.6)
Hypertension Poor cognition 96 (6.8)
Hypertension Arthritis 94 (6.6)
Hypertension Diabetes 91 (6.4)
Limitations / Lower body Limitations / Strength 73 (5.1)
Hypertension Limitations / Lower body 61 (4.3)
Arthritis Limitations / Lower body Limitations / Strength 59 (5.2)
Hypertension Limitations / Lower body Limitations / Strength 53 (4.7)
Hypertension Arthritis Limitations / Strength 46 (4.1)
Hypertension Arthritis Limitations / Lower body 27 (2.4)
Hypertension Arthritis Diabetes 23 (2.0)
Hypertension Limitations / Lower body Limitations / Strength Arthritis 84 (8.4)
Arthritis Limitations / Lower body Limitations / Strength Limitations / Upper body 37 (3.7)
Hypertension Limitations / Lower body Limitations / Strength Limitations / Upper body 21 (2.1)
Hypertension Limitations / Lower body Limitations / Strength Impaired vision 16 (1.6)
Arthritis Limitations / Lower body Limitations / Strength Poor cognition 15 (1.5)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Limitations / Upper body 34 (4.5)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Diabetes 33 (4.4)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Poor cognition 14 (1.9)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Incontinence 11 (1.5)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Cancer 11 (1.5)
1,401 (15.4)
1,422 (15.6)
1,132 (12.4)
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756 (8.3)
1
Co
n
di
tio
n
2
Co
nd
itio
ns
3
Co
n
di
tio
ns
4
Co
n
di
tio
ns
5
Co
n
di
tio
ns
Table 3B Most frequent combinations of conditions constituting multimorbidity among adults aged ≥65 years, by number of conditions (top five only). 
N (%) N (% of total n=8,801)
Hypertension 120 (32.1)
Arthritis 65 (17.4)
Poor cognition 40 (10.7)
Cancer 29 (7.8)
Heart Disease 21 (5.6)
Hypertension Arthritis 80 (12.9)
Hypertension Heart disease 36 (5.8)
Hypertension Poor cognition 35 (5.6)
Arthritis Incontinence 31 (5.0)
Arthritis Limitations / Lower body 25 (4.0)
Arthritis Limitations / Lower body Limitations / Strength 51 (6.2)
Hypertension Arthritis Limitations / Strength 47 (5.7)
Hypertension Arthritis Limitations / Lower body 39 (4.7)
Hypertension Arthritis Heart Disease 27 (3.3)
Hypertension Arthritis Poor Cognition 22 (2.7)
Hypertension Arthritis Limitations / Lower body Limitations / Strength 101 (10.6)
Arthritis Limitations / Upper body Limitations / Lower body Limitations / Strength 20 (2.1)
Arthritis Limitations / Upper body Limitations / Strength Incontinence 17 (1.8)
Hypertension Arthritis Limitations / Strength Cancer 16 (1.7)
Arthritis Limitations / Lower body Limitations / Strength Poor cognition 14 (1.5)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Limitations / Upper body 60 (5.8)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Incontinence 36 (3.5)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Poor cognition 34 (3.3)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Heart disease 34 (3.3)
Hypertension Arthritis Limitations / Lower body Limitations / Strength Diabetes 23 (2.2)
374 (4.2)
620 (7.0)
826 (9.4)
950 (10.8)
1,042 (11.8)
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older adults, we evaluated the MM burden by examin-
ing the count of CCMM across sociodemographic strata, 
as well as in terms of Medicare expenditures. We con-
ducted this analysis using data for all HRS participants, 
as well as on the subset of HRS participants who are also 
Medicare FFS beneficiaries. Our findings indicate that 
functional limitations and geriatric syndromes consider-
ably add to the MM burden in midlife and older adults, 
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and that expenditures increase sharply with higher 
counts of CCMM.
The disproportionate consumption of Medicare 
expenditure by individuals with multiple chronic 
conditions has been reported previously, though the 
extent of the disproportionality varies across different 
sources [25–27]. In a Robert Wood Johnson Founda-
tion chartbook, Anderson reported that two thirds of 
the Medicare expenditure is incurred by individuals 
with five or more chronic conditions [25], while data 
from the CMS indicate that 15% of Medicare FFS bene-
ficiaries present with six or more chronic conditions, but 
incur 51% of the Medicare expenditures [26]. While our 
measures are not directly comparable to the ones used 
in the aforementioned reports, we note that by incor-
porating functional limitations and geriatric syndromes 
in our count of CCMM, we demonstrate a considerably 
greater burden associated with MM: among Medicare 
beneficiaries aged 50–64 years, 68% presented with 
six or more CCMM and incurred 83% of the Medi-
care expenditures. Among beneficiaries aged ≥65 years, 
these percentages were 58% and 79%, respectively. Our 
findings show that a greater count of CCMM is asso-
ciated with higher expenditures, possibly as a result of 
co-occurring functional limitations and geriatric syn-
dromes. The contribution of functional limitations to 
higher expenditure is supported by our more recent 
study [28] in which 64% of individuals aged ≥65 years 
with self-rated poor health, as well as limitations in ADL 
and IADL, incurred expenditures in the top quartile, 
highlighting the importance of functional limitations in 
explaining resource use. We note, however, that in our 
current study, even our statistics may underestimate the 
burden of MM, given that we limited our list of chronic 
conditions to the eight self-reported in the HRS. The 
burden would be considerably higher if our algorithm 
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implications relative to health and healthcare outcomes 
[36–40], health services utilization, including hospitaliza-
tions and readmissions [41,42], as well as to clinical practice 
and healthcare policy. First, we believe that these data 
strongly support the notion that MM in midlife and older 
adults is the norm, rather than the exception, and – given 
the heterogeneous combinations of the various condi-
tions that we identify – that the care they receive must be 
 person-centered, rather than disease/condition-centered. 
Second, our findings call for the wide adoption of such 
instruments as the Comprehensive Geriatric Assessment 
[43] to routinely evaluate patients’ physical, mental, affec-
tive, and sensory functioning, and to identify subgroups of 
the midlife and older adults who are most vulnerable to 
experience adverse outcomes. Similarly, these findings call 
for the expansion and broader adoption of such programs 
as Independence at Home [44], authorized by the Affordable 
Care Act to provide primary care home visits to individuals 
with multiple chronic conditions and functional limita-
tions. This demonstration program, aimed at improving 
patient and caregiver satisfaction and reducing the need 
for hospitalization, has yielded savings of over USD 1,000 
per beneficiary [44]. However, it is important that such 
programs also place emphasis on geriatric syndromes for 
eligibility criteria. By doing so, the program would have a 
considerably greater impact relative to prevention as well. 
For example, poor cognitive performance alone may not 
qualify an individual for such a program; yet, it is listed as 
one of the most frequent conditions, and part of the most 
common dyads that also includes hypertension. Based on 
the circular association between chronic conditions and 
geriatric syndromes described earlier, a person with hyper-
tension who also has cognitive impairment is likely to 
suffer poor self-management, therefore poor blood pressure 
control and complications. Finally, our findings call for the 
availability of multidisciplinary care teams, and health-
care providers who can help community-dwelling midlife 
and older adults, not only with the management of their 
chronic conditions but also with their functional, cog-
nitive, and sensory impairments. Such assistance may be 
paramount to helping individuals stay at home and delay, 
or even prevent institutionalization.
Findings from this study also have implications 
regarding MM burden in midlife adults. Indeed, as 
shown in Table 1, nearly 28% of those aged 50–64 years 
have ≥6 CCMMs. These statistics inform us of the antic-
ipated MM burden in incoming cohorts of Medicare 
beneficiaries.
In conclusion, the prominence of co-occurring func-
tional limitations and geriatric syndromes in CCMMs 
provides a basis for developing clinical systems that con-
sider the interaction among co-existing conditions and 
treatments, and the needed resource allocation. Studies 
on MM bear increasingly greater significance, especially 
relied on a broader range of chronic conditions identi-
fied from claims data. 
Despite the difference in the study measures, the 
high burden of MM shown in our current analysis is 
somewhat consistent with a report by the Agency for 
Healthcare Research and Quality (AHRQ), indicating 
that 80% of individuals aged ≥65 years have multiple 
chronic conditions [27], using data from the Medical 
Expenditure Panel Survey, and Hwang’s definition of 
chronic condition as “one that lasted or was expected to last 
twelve or more months and resulted in functional limitations, 
and/or the need for ongoing medical care” [29]. Data from the 
AHRQ report also indicate that 45% of individuals with 
multiple chronic conditions have functional limitations, 
including ADL, IADL, as well as any functional, activ-
ity, or sensory limitations [28]. 
Our results are also comparable to that of a recent study 
by McClintock et al. [30] who assessed population health 
based on a Comprehensive Model, which, in contrast to the 
Medical Model, incorporates elements of health as defined 
by the World Health Organization (e.g. mental health). 
Using data from the National Social Life, Health, and 
Aging Project, and latent class analysis, the Comprehensive 
Model identified six health classes, including two classes, in 
which mental health (loneliness), hearing impairment, and 
bone fractures emerged as important conditions in defining 
vulnerable health classes. In addition, whereas the Medical 
Model grouped two thirds of the population into “robust 
health” classes, the Comprehensive Model classified half 
of the population as having significant vulnerabilities that 
would impact their health outcomes. 
Regarding CCMM, our findings failed to identify 
large groups of individuals with specific combinations 
of CCMMs (Tables 3A and 3B), but did identify combi-
nations of CCMMs that co-occur frequently (Tables 2A 
and 2B). This attests to the heterogeneity of individuals 
with MM or multiple chronic conditions, as reported 
by Whitson et al. [31]. A notable finding, however, is 
that in individuals with two or more CCMM, we begin 
observing the prominence of functional limitations and 
geriatric syndromes. In particular, functional limitations 
are almost always present in individuals presenting with 
three or more CCMM. In addition, the combination of 
limitations of lower body functioning and strength limi-
tations are the most frequently observed dyad, regardless 
of whether they co-occur with other conditions, pre-
senting in 37.2% of individuals aged 50–64 years of age, 
and in 57.5% of individuals aged ≥65 years.
These results have important implications both in 
research and in clinical practice, warranting a shift of par-
adigm to account for functional limitations and geriatric 
syndromes when studying MM and not simply focusing 
on chronic conditions. In addition to being closely inter- 
related [32–35], the former conditions also have important 
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